Instantaneous wave-free ratio (iFR) can safely guide revascularization decisions in left anterior descending (LAD) arteries with moderate stenosis, according to an analysis of the DEFINE-FLAIR study published in the Journal of the American College of Cardiology. 

The interventional cardiology residency program at Detroit Medical Center will undergo an accreditation inspection Feb. 8 following controversial leadership changes within the organization last fall, Crain’s Detroit Business reported.

Patients undergoing heart surgery might see better outcomes and shorter hospital stays if they opt for intraoperative autologous blood donation, according to research out of New York.

The Society for Cardiovascular Angiography and Interventions (SCAI) weighed in on the ongoing debate regarding the long-term safety of paclitaxel-coated balloons and stents on Jan. 25, largely agreeing with the FDA’s stance that the benefits of such devices appear to outweigh the risks until more information becomes available.

LEIPZIG and MARLBOROUGH, Mass. (January 22, 2019) — Boston Scientific (NYSE: BSX) today announced diabetic subanalysis results from the IMPERIAL trial in which patients treated with the ELUVIA™ Drug-Eluting Vascular Stent System demonstrated statistically significant lower rates of target lesion revascularization (TLR) and stent thrombosis when compared to those treated with the Zilver® PTX® Drug-Eluting Peripheral Stent. 

A survey of cardiovascular fellows-in-training (FIT) offered insight into why women at that career stage are less likely to pursue interventional cardiology—a subspecialty that ranks among the lowest in all of medicine in terms of female representation.

Rivaroxaban failed to reduce the rate of early graft failure following coronary artery bypass graft (CABG) surgery compared to aspirin monotherapy, researchers reported in a substudy of the COMPASS trial published Jan. 14 in the Journal of the American College of Cardiology.

One in five patients who required emergency surgery to correct complications caused by diagnostic angiography or percutaneous coronary intervention (PCI) died within 30 days, researchers reported in a single-center study from Germany.